Fernando Caravaca-Fontán1,2, Montserrat Díaz-Encarnación3, Virginia Cabello4, Gema Ariceta5, Luis F Quintana6,7, Helena Marco8, Xoana Barros9, Natalia Ramos10, Nuria Rodríguez-Mendiola11, Sonia Cruz12, Gema Fernández-Juárez13, Adela Rodríguez14, Ana Pérez de José15, Cristina Rabasco16, Raquel Rodado17, Loreto Fernández18, Vanessa Pérez Gómez19, Ana Ávila20, Luis Bravo21, Natalia Espinosa22, Natalia Allende23, Maria Dolores Sanchez de la Nieta24, Eva Rodríguez25, Teresa Olea26, Marta Melgosa27, Ana Huerta28, Rosa Miquel29, Carmen Mon30, Gloria Fraga31, Alberto de Lorenzo32, Juliana Draibe33, Marta Cano-Megías34, Fayna González35, Amir Shabaka36, Maria Esperanza López-Rubio37, María Ángeles Fenollosa38, Luis Martín-Penagos39, Iara Da Silva3, Juana Alonso Titos40, Santiago Rodríguez de Córdoba41,42, Elena Goicoechea de Jorge1,43, Manuel Praga1,2. 1. Instituto de Investigación Hospital 12 de Octubre (imas12), Madrid, Spain. 2. Department of Medicine, Universidad Complutense de Madrid, Madrid, Spain. 3. Department of Nephrology, Fundación Puigvert, Barcelona, Spain. 4. Department of Nephrology, Hospital Universitario Virgen del Rocío, Sevilla, Spain. 5. Department of Pediatric Nephrology, Hospital Universitario Vall d'Hebron, Universidad Autónoma de Barcelona, Barcelona, Spain. 6. Department of Nephrology and Renal Transplantation, Hospital Clinic de Barcelona, Barcelona, Spain. 7. Department of Medicine, University of Barcelona, IDIBAPS, Barcelona, Spain. 8. Department of Nephrology, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain. 9. Department of Nephrology, Hospital Universitario Doctor Josep Trueta, Gerona, Spain. 10. Department of Nephrology, Hospital Universitario Vall d'Hebron, Barcelona, Spain. 11. Department of Nephrology, Hospital Universitario Ramón y Cajal, Madrid, Spain. 12. Department of Nephrology, Hospital Universitario Juan Ramón Jiménez, Huelva, Spain. 13. Department of Nephrology, Hospital Universitario Fundación Alcorcón, Madrid, Spain. 14. Department of Pediatric Nephrology, Hospital Universitario Virgen del Rocío, Sevilla, Spain. 15. Department of Nephrology, Hospital Universitario Gregorio Marañón, Madrid, Spain. 16. Department of Nephrology, Hospital Universitario Reina Sofía, Córdoba, Spain. 17. Department of Nephrology, Hospital Universitario Virgen de la Arrixaca, Murcia, Spain. 18. Department of Nephrology, Complejo Hospitalario de Navarra, Navarra, Spain. 19. Department of Nephrology, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain. 20. Department of Nephrology, Hospital Universitario Doctor Peset, Valencia, Spain. 21. Department of Nephrology, Hospital Universitario A Coruña, La Coruña, Spain. 22. Pediatric Nephrology Unit, Hospital Universitario Son Espases, Balearic Islands Health Research Institute (IdISBa), Palma de Mallorca, Spain. 23. Department of Nephrology, Hospital Universitario Son Espases, Palma de Mallorca, Spain. 24. Department of Nephrology, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain. 25. Department of Nephrology, Hospital del Mar, Barcelona, Spain. 26. Department of Nephrology, Hospital Universitario La Paz, Madrid, Spain. 27. Department of Pediatric Nephrology, Hospital Universitario La Paz, Madrid, Spain. 28. Department of Nephrology, Hospital Universitario Puerta de Hierro, Madrid, Spain. 29. Department of Nephrology, Hospital Universitario Canarias, Tenerife, Spain. 30. Department of Nephrology, Hospital Universitario Severo Ochoa, Leganés, Madrid, Spain. 31. Department of Pediatric Nephrology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain. 32. Department of Nephrology, Hospital Universitario de Getafe, Madrid, Spain. 33. Department of Nephrology, Hospital Universitario de Bellvitge, Barcelona, Spain. 34. Department of Nephrology, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, Spain. 35. Department of Nephrology, Hospital Doctor Negrín, Gran Canaria, Spain. 36. Department of Nephrology, Hospital Universitario Clínico San Carlos, Madrid, Spain. 37. Department of Nephrology, Complejo Hospitalario Universitario de Albacete, Albacete, Spain. 38. Department of Nephrology, Hospital General Universitario de Castellón, Castellón, Spain. 39. Department of Nephrology, Hospital Universitario Marqués de Valdecilla, Santander, Spain. 40. Department of Nephrology, Hospital Regional Universitario Carlos Haya, Málaga, Spain. 41. Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas, Madrid, Spain. 42. Centro de Investigación Biomédica en Red en Enfermedades Raras, Madrid, Spain. 43. Department of Immunology, Universidad Complutense de Madrid, Madrid, Spain.
Abstract
INTRODUCTION: The association between a change in proteinuria over time and its impact on kidney prognosis has not been analysed in complement component 3 (C3) glomerulopathy. This study aims to investigate the association between the longitudinal change in proteinuria and the risk of kidney failure. METHODS: This was a retrospective, multicentre observational cohort study in 35 nephrology departments belonging to the Spanish Group for the Study of Glomerular Diseases. Patients diagnosed with C3 glomerulopathy between 1995 and 2020 were enrolled. A joint modelling of linear mixed-effects models was applied to assess the underlying trajectory of a repeatedly measured proteinuria, and a Cox model to evaluate the association of this trajectory with the risk of kidney failure. RESULTS: The study group consisted of 85 patients, 70 C3 glomerulonephritis and 15 dense deposit disease, with a median age of 26 years (range 13-41). During a median follow-up of 42 months, 25 patients reached kidney failure. The longitudinal change in proteinuria showed a strong association with the risk of this outcome, with a doubling of proteinuria levels resulting in a 2.5-fold increase of the risk. A second model showed that a ≥50% proteinuria reduction over time was significantly associated with a lower risk of kidney failure (hazard ratio 0.79; 95% confidence interval 0.56-0.97; P < 0.001). This association was also found when the ≥50% proteinuria reduction was observed within the first 6 and 12 months of follow-up. CONCLUSIONS: The longitudinal change in proteinuria is strongly associated with the risk of kidney failure. The change in proteinuria over time can provide clinicians a dynamic prediction of kidney outcomes.
INTRODUCTION: The association between a change in proteinuria over time and its impact on kidney prognosis has not been analysed in complement component 3 (C3) glomerulopathy. This study aims to investigate the association between the longitudinal change in proteinuria and the risk of kidney failure. METHODS: This was a retrospective, multicentre observational cohort study in 35 nephrology departments belonging to the Spanish Group for the Study of Glomerular Diseases. Patients diagnosed with C3 glomerulopathy between 1995 and 2020 were enrolled. A joint modelling of linear mixed-effects models was applied to assess the underlying trajectory of a repeatedly measured proteinuria, and a Cox model to evaluate the association of this trajectory with the risk of kidney failure. RESULTS: The study group consisted of 85 patients, 70 C3 glomerulonephritis and 15 dense deposit disease, with a median age of 26 years (range 13-41). During a median follow-up of 42 months, 25 patients reached kidney failure. The longitudinal change in proteinuria showed a strong association with the risk of this outcome, with a doubling of proteinuria levels resulting in a 2.5-fold increase of the risk. A second model showed that a ≥50% proteinuria reduction over time was significantly associated with a lower risk of kidney failure (hazard ratio 0.79; 95% confidence interval 0.56-0.97; P < 0.001). This association was also found when the ≥50% proteinuria reduction was observed within the first 6 and 12 months of follow-up. CONCLUSIONS: The longitudinal change in proteinuria is strongly associated with the risk of kidney failure. The change in proteinuria over time can provide clinicians a dynamic prediction of kidney outcomes.
Authors: Hannah J Lomax-Browne; Nicholas R Medjeral-Thomas; Sean J Barbour; Jack Gisby; Heedeok Han; Andrew S Bomback; Fernando C Fervenza; Thomas H Cairns; Richard Szydlo; Sven-Jean Tan; Stephen D Marks; Aoife M Waters; Gerald B Appel; Vivette D D'Agati; Sanjeev Sethi; Cynthia C Nast; Ingeborg Bajema; Charles E Alpers; Agnes B Fogo; Christoph Licht; Fadi Fakhouri; Daniel C Cattran; James E Peters; H Terence Cook; Matthew C Pickering Journal: Clin J Am Soc Nephrol Date: 2022-07 Impact factor: 10.614
Authors: Fernando Caravaca-Fontán; Marta Rivero; Teresa Cavero; Montserrat Díaz-Encarnación; Virginia Cabello; Gema Ariceta; Luis F Quintana; Helena Marco; Xoana Barros; Natalia Ramos; Nuria Rodríguez-Mendiola; Sonia Cruz; Gema Fernández-Juárez; Adela Rodríguez; Ana Pérez de José; Cristina Rabasco; Raquel Rodado; Loreto Fernández; Vanessa Pérez-Gómez; Ana Ávila; Luis Bravo; Natalia Espinosa; Natalia Allende; Maria Dolores Sanchez de la Nieta; Eva Rodríguez; Teresa Olea; Marta Melgosa; Ana Huerta; Rosa Miquel; Carmen Mon; Gloria Fraga; Alberto de Lorenzo; Juliana Draibe; Fayna González; Amir Shabaka; Maria Esperanza López-Rubio; María Ángeles Fenollosa; Luis Martín-Penagos; Iara Da Silva; Juana Alonso Titos; Santiago Rodríguez de Córdoba; Elena Goicoechea de Jorge; Manuel Praga Journal: Clin Kidney J Date: 2022-04-28
Authors: Andrew S Bomback; David Kavanagh; Marina Vivarelli; Matthias Meier; Yaqin Wang; Nicholas J A Webb; Angelo J Trapani; Richard J H Smith Journal: Kidney Int Rep Date: 2022-08-02